EGR3 gene expression has previously been shown to increase in breast-cancer-associated fibroblasts after treatment with taxotere43, and furthermore it has been shown that tissue samples from patients with recurrent breast cancer had elevated levels of EGR3 compared to the matched primary tumours44. The gene discussed is EGR3; the disease is breast carcinoma.